Form 4 for CRVO CervoMed Inc.
Accepted 2022-02-02 00:00:00 ET · period of report 2022-01-31 · accession 0001437749-22-002262 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-02 | 2022-01-31 | CRVO | Cobuzzi Robert Joseph Jr. | Pres, CEO, Dir | M - OptEx | — | +16.4K | 40.7K | +67% | — |
| D | 2022-02-02 | 2022-01-31 | CRVO | Cobuzzi Robert Joseph Jr. | Pres, CEO, Dir | D - Sale to Iss | — | -6,049 | 34.6K | -15% | — |
| D | 2022-02-02 | 2022-01-31 | CRVO | Cobuzzi Robert Joseph Jr. | Pres, CEO, Dir | M - OptEx | $0.00 | -16.4K | 65.4K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-31 | M | A | 16,350 | — | 40,651 | D | — | — | (F1) On January 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. |
| 2 | Common | Common Stock | 2022-01-31 | D | D | 6,049 | — | 34,602 | D | — | — | (F1) On January 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. |
| 3 | Derivative | Restricted Stock Unit | 2022-01-31 | M | D | 16,350 | $0.00 | 65,400 | D | — · — to — | 16,350 Common Stock | (F1) On January 31, 2022 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer. |